SCHEMBL24628012

SCHEMBL24628012

CCCCCCCCC(CCCCCCCC)OC(=O)CCN(CCCCN1CCCCC1)CCC(=O)OC(CCCCCCCC)CCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.45
BCHE P06276 7/20 0.41
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPK1 P28482 2/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 3/20 0.39
THRA P10827 2/20 0.39
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
ADRA2C P18825 1/20 0.36
DRD4 P21917 1/20 0.36
ACHE P22303 1/20 0.36
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627862 0.99 GAA (0.43) GAABCHEALDH1A1L3MBTL1MAPK1
SCHEMBL24627697 0.95 GAA (0.47) GAABCHEALDH1A1L3MBTL1MAPK1
SCHEMBL24628004 0.93 GAA (0.47) GAABCHEALDH1A1L3MBTL1MAPK1
SCHEMBL24627850 0.91 GAA (0.45) GAABCHEALDH1A1L3MBTL1MAPK1
SCHEMBL24628009 0.91 PAOX (0.43) GAABCHEALDH1A1MAPK1MAPT
SCHEMBL30966075 0.91 PAOX (0.43) GAABCHEALDH1A1MAPK1MAPT
SCHEMBL17367570 0.91 GAA (0.47) GAAALDH1A1L3MBTL1MAPK1MAPT
SCHEMBL24627622 0.91 PAOX (0.43) GAABCHEALDH1A1MAPK1MAPT
SCHEMBL25525594 0.87 ALDH1A1 (0.47) GAAALDH1A1L3MBTL1MAPK1MAPT
SCHEMBL24627804 0.86 MAPK1 (0.44) GAAALDH1A1MAPK1MAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF NPC1L1, PLA2G4A, PLA2G2A GAA 975/4885BCHE 3491/4885ALDH1A1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.